Research programme: organophosphorus compound - AEterna Zentaris

Drug Profile

Research programme: organophosphorus compound - AEterna Zentaris

Alternative Names: AEZS 127; EPC; ErPC; Erucyl-phosphocholine; ZEN 027

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AEterna Zentaris Inc
  • Class Antifungals; Antineoplastics; Antiprotozoals; Organophosphorus compounds; Small molecules
  • Mechanism of Action Signal transduction pathway inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Germany (IV, Injection)
  • 11 May 2012 Preclinical development is ongoing
  • 09 Jul 2009 Preclinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top